131 related articles for article (PubMed ID: 698036)
41. The influence of nonspecific immunotherapy on the course of murine melanoma.
Woods JE; Ritts RE
J Surg Oncol; 1977; 9(1):15-20. PubMed ID: 839793
[TBL] [Abstract][Full Text] [Related]
42. Effect of vaccine prepared from Corynebacterium parvum on the growth of Gardner lymphosarcoma in C3H strain mice.
Motycka K; Chudomel V; Bednár M; Bostík J
Arch Immunol Ther Exp (Warsz); 1984; 32(4):405-12. PubMed ID: 6549499
[TBL] [Abstract][Full Text] [Related]
43. Effect of excision or local radiotherapy to a tumor and its regional nodes on metastases.
McCredie JA; Inch WR; Cowie HC
Cancer; 1973 Apr; 31(4):983-7. PubMed ID: 4706059
[No Abstract] [Full Text] [Related]
44. Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma.
Woodruff MF; Dunbar N
Br J Cancer; 1975 Jul; 32(1):34-41. PubMed ID: 1080671
[TBL] [Abstract][Full Text] [Related]
45. Enhancement of concomitant immunity after radiation therapy and immunotherapy in a syngeneic murine tumour system.
Deneufbourg JM
Acta Radiol Oncol; 1982; 21(5):345-8. PubMed ID: 6297254
[TBL] [Abstract][Full Text] [Related]
46. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
Likhite VV
J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
[TBL] [Abstract][Full Text] [Related]
47. Effects of dose and schedule of immune stimulant on efficacy of combination Corynebacterium parvum-cyclophosphamide treatment for a murine mammary adenocarcinoma.
Purnell DM; Bartlett GL; Kreider JW
Cancer Res; 1979 Jan; 39(1):1-5. PubMed ID: 761179
[TBL] [Abstract][Full Text] [Related]
48. Improved survival after pneumococcus in splenectomized and nonsplenectomized mice with Corynebacterium parvum.
Hebert JC; Gamelli RL; Foster RS; Chalmer BJ; Davis JH
Arch Surg; 1983 Mar; 118(3):328-32. PubMed ID: 6824432
[TBL] [Abstract][Full Text] [Related]
49. Antimetastatic effect of cell-wall skeleton of Propionibacterium acnes C7 on Lewis lung carcinoma in C57BL/6J mice.
Tanio Y; Yamamura Y; Saiki I; Okumura H; Kamisango K; Okuyama H; Azuma I
Gan; 1981 Jun; 72(3):403-10. PubMed ID: 7319198
[TBL] [Abstract][Full Text] [Related]
50. Phase I study of corynebacterium parvum in patients with solid tumors.
Band PR; Jao-King C; Urtasun RC; Haraphongse M
Cancer Chemother Rep; 1975; 59(6):1139-45. PubMed ID: 769953
[TBL] [Abstract][Full Text] [Related]
51. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
Kreider JW; Bartlett GL; Purnell DM; Webb S
Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
[TBL] [Abstract][Full Text] [Related]
52. Morphological and functional aspects of active specific immunotherapy of established pulmonary metastases in guinea pigs.
Hanna MG; Peters LC
Cancer Res; 1981 Oct; 41(10):4001-9. PubMed ID: 7285011
[No Abstract] [Full Text] [Related]
53. Regression of a transplantable hamster melanoma by intralesional injections of Corynebacterium granulosum.
Paslin D; Dimitrov NV; Heaton C
J Natl Cancer Inst; 1974 Feb; 52(2):571-3. PubMed ID: 4593141
[No Abstract] [Full Text] [Related]
54. Role of T-cell subsets in the destruction of established metastases of 13762A rat mammary adenocarcinoma.
Howell LE; Kreider JW; Bartlett GL
J Natl Cancer Inst; 1986 Jul; 77(1):187-93. PubMed ID: 3487670
[TBL] [Abstract][Full Text] [Related]
55. Experience with the quality control testing of C. parvum suspension for clinical trial.
Knight PA; Lucken RN
Dev Biol Stand; 1977 Apr 13-15; 38():51-8. PubMed ID: 608544
[TBL] [Abstract][Full Text] [Related]
56. Effect of glucan and other adjuvants on the clearance of radiolabeled tumor cells from mouse lungs.
Proctor JW; Stiteler RD; Yamamura Y; Mansell PW; Winters R
Cancer Treat Rep; 1978 Nov; 62(11):1873-80. PubMed ID: 728905
[TBL] [Abstract][Full Text] [Related]
57. Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancer.
Thatcher N; Honeybourne D; Wagstaff J; Carroll KB; Barber PV; Morrison JB; Crowther D
Br J Dis Chest; 1984 Jan; 78(1):89-97. PubMed ID: 6318791
[TBL] [Abstract][Full Text] [Related]
58. Failure of Corynebacterium parvum presensitization to modify the antitumor effects of systemic and local therapeutic injections of C. parvum in mice.
Scott MT
J Natl Cancer Inst; 1976 Mar; 56(3):675-7. PubMed ID: 815560
[TBL] [Abstract][Full Text] [Related]
59. Combination chemoimmunotherapy for extensive non-oat cell lung cancer.
Issell BF; Valdivieso M; Hersh EM; Richman S; Gutterman JU; Bodey GP
Cancer Treat Rep; 1978 Jul; 62(7):1059-63. PubMed ID: 356968
[TBL] [Abstract][Full Text] [Related]
60. Immunotherapy of cancer with corynebacterium parvum.
Halpern B
Ann Allergy; 1978 Mar; 40(3):155-7. PubMed ID: 637374
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
